Industry Symposium Supported by Gilead & Kite and Arcellx: CAR T: Has Multiple Myeloma Finally Met Its Match?

Chair(s)

• 

  Sham Mailankody, MBBS

  Associate Attending Physician, Myeloma Service
  Memorial Sloan Kettering Cancer Center
  New York, New York

Presentations:

• 17:30 - 17:35 East Coast USA Time

  Welcome and Introductions
  

  Speaker: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center
• 17:35 - 17:50 East Coast USA Time

  The Unmet Needs in Multiple Myeloma
  

  Speaker: Michael Sebag, MD, PhD (he/him/his) – McGill University Health Centre
• 17:50 - 18:05 East Coast USA Time

  The Role of CAR T-Cell Therapy in Multiple Myeloma
  

  Speaker: Judith S. Hecker, PD Dr. med. (she/her/hers) – TUM University Hospital, Munich Germany
• 18:05 - 18:25 East Coast USA Time

  Novel Targets and the Evolving Role of CAR T
  

  Speaker: Ciara L. Freeman, Dr (she/her/hers) – H Lee Moffitt Cancer Center and Research Institute
• 18:25 - 18:30 East Coast USA Time

  Summary and Close
  

  Speaker: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center